TGA
In The News
Today in our news roundup: warnings over the timing of TGA staff cuts, and more revelations about big pharma’s business practices No time for cutbacks Revelations that the TGA plans …
Codeine decision by May
Rescheduling review announced by department as May decision date looms A decision on the controversial rescheduling of codeine is expected by May 2016, following a safety review, Department of Health …
ASMI warns consumers against buying CMs from overseas
ASMI says consumers should only purchase complementary medicines approved for supply in Australia because they are highly regulated by the TGA. “Australia’s system of regulating complementary medicines is one of …
Naloxone downschedule will save lives: Angelo Pricolo
The TGA has recommended that naloxone minijet be scheduled to Pharmacist Only medicine—a decision which will likely save lives, says Angelo Pricolo, the Brunswick pharmacist who made the submission. This …
ACMS interim decision: OTC codeine could go S4
The Pharmacy Guild of Australia has expressed concern at the proposed re-scheduling of codeine containing analgesics to Schedule 4, Prescription Only Medicine. The interim decision of the Advisory Committee on …
Ley slams pharma companies on delaying tactics
Health Minister Sussan Ley has criticised pharmaceutical companies for dragging their feet on bringing new drugs to the Australian market and prioritising applying to lucrative markets overseas. “Australia has a …
PWC outlines medicines industry challenges: Medicines Australia
The 2015 PricewaterhouseCoopers survey of the Australian medicines industry provides an important and timely insight into the challenges and opportunities confronting the Australian innovative medicines industry, says Medicines Australia. The …
Regulatory headaches stifling access to medicines: PwC report
TGA regulation, price pressure and compliance issues are reducing access to medicines, and reducing industry confidence, a PwC report claims. Challenges and Change—a report on the Australian pharmaceutical industry, released …
More children’s medicines recalled over lids issue
The TGA has advised that more children’s medicines are being recalled, because they have been supplied in bottles where grooves that secure the lids can break off during opening. The …
Don’t mandate country of origin labelling: ASMI
ASMI has said country of origin statements, graphics and visual representations should not be mandatory for therapeutic goods labels, in its submission to the Government’s review of country of origin …
CMA calls for less health red tape, more innovation support
In a submission to the Department of Health on reducing regulation in the health portfolio, Complementary Medicines Australia has reiterated its support of the Government’s commitment to foster a regulatory …
Drug companies cause slow access to new medicines: Ley
Health Minister Sussan Ley says she wants to turn around the issue of ‘slow’ access to new medicines, which she says is caused by drug companies. Medicines manufacturers prefer to …